Panoramic Capital Partners’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-972
Closed -$211K 73
2026
Q1
$211K Buy
972
+29
+3% +$6.43K 0.13% 61
2025
Q4
$215K Buy
943
+6
+0.6% +$1.37K 0.13% 59
2025
Q3
$217K Buy
+937
New +$191K 0.14% 55

Other funds holding ABBV

Panoramic Capital Partners's ABBV Position: Q2 2026 in Review

Panoramic Capital Partners sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 972 shares — an estimated $211K sold.

Panoramic Capital Partners first reported a position in ABBV in Q3 2025 and held it in 3 quarters. The position peaked at $217K in Q3 2025. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Panoramic Capital Partners reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
  • Panoramic Capital Partners sold 972 AbbVie shares in Q2 2026, an estimated $211K.
  • Panoramic Capital Partners first reported a position in AbbVie in Q3 2025 and held it in 3 quarters.
  • Panoramic Capital Partners's AbbVie position peaked at $217K in Q3 2025.
  • 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Panoramic Capital Partners's 13F filing for Q2 2026, filed 7 Aug 2026.